A comprehensive model for the humoral coagulation network in humans

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 3, 2009, Pages 290-298

  Wajima, T ^a,b   Isbister, G K ^c,d   Duffull, S B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b SHIONOGI AND CO LTD   (Japan)

^c CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; ENOXAPARIN; HEPARIN; VITAMIN K GROUP; WARFARIN;

ACCURACY; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEMOPHILIA; IN VITRO STUDY; IN VIVO STUDY; KINETICS; PARTIAL THROMBOPLASTIN TIME; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; SINGLE DRUG DOSE; TIME;

ALGORITHMS; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; COMPUTER SIMULATION; HEMOPHILIA A; HEMOSTATICS; HEPARIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; KINETICS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE OF TESTS; PROTHROMBIN TIME; SNAKE BITES; VITAMIN K; WARFARIN;

EID: 69449108221     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.87     Document Type: Article

References (39)

1. Riddel, J.P. Jr, Aouizerat, B.E., Miaskowski, C. & Lillicrap, D.P. Theories of blood coagulation. J. Pediatr. Oncol. Nurs. 24, 123-131 (2007).
2. Hoffman, M.M. & Monroe, D.M. Rethinking the coagulation cascade. Curr. Hematol. Rep. 4, 391-396 (2005).
3. Wadelius, M. & Pirmohamed, M. Pharmacogenetics of warfarin: current status and future challenges. Pharmacogenomics J. 7, 99-111 (2007). (Pubitemid 46567142)
4. Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A. & Hylek, E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(suppl.), 204S-233S (2004). (Pubitemid 39297954)
5. Hirsh, J. & Raschke, R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(suppl.), 188S-203S (2004). (Pubitemid 39297951)
6. Gray, E., Mulloy, B. & Barrowcliffe, T.W. Heparin and low-molecular-weight heparin. Thromb. Haemost. 99, 807-818 (2008).
7. Furie, B., Bouchard, B.A. & Furie, B.C. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 93, 1798 - 1808 (1999).
8. Tanos, P.P., Isbister, G.K., Lalloo, D.G., Kirkpatrick, C.M. & Duffull, S.B. A model for venom-induced consumptive coagulopathy in snake bite. Toxicon. 52, 769-780 (2008).
9. Mann, K.G., Butenas, S. & Brummel, K. The dynamics of thrombin formation. Arterioscler. Thromb. Vasc. Biol. 23, 17-25 (2003).
10. Khanin, M.A. & Semenov, V.V. A mathematical model of the kinetics of blood coagulation. J. Theor. Biol. 136, 127-134 (1989).
11. Zarnitsina, V.I., Pokhilko, A.V. & Ataullakhanov, F.I. A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. II Results. Thromb. Res. 84, 333-344 (1996).
12. Monroe, D.M., Hoffman, M. & Roberts, H.R. Platelets and thrombin generation. Arterioscler. Thromb. Vasc. Biol. 22, 1381-1389 (2002).
13. Hockin, M.F., Cawthern, K.M., Kalafatis, M. & Mann, K.G. A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition. Biochemistry 38, 6918-6934 (1999). (Pubitemid 129514994)
14. Qiao, Y.H., Xu, C.Q., Zeng, Y.J., Xu, X.H., Zhao, H. & Xu, H. The kinetic model and simulation of blood coagulation - the kinetic influence of activated protein C. Med. Eng. Phys. 26, 341-347 (2004). (Pubitemid 38584586)
15. Qiao, Y.H., Liu, J.L. & Zeng, Y.J. A kinetic model for simulation of blood coagulation and inhibition in the intrinsic path. J. Med. Eng. Technol. 29, 70-74 (2005).
16. Ataullakhanov, F.I. & Panteleev, M.A. Mathematical modeling and computer simulation in blood coagulation. Pathophysiol. Haemost. Thromb. 34, 60-70 (2005).
17. Pohl, B., Beringer, C., Bomhard, M. & Keller, F. The quick machine - a mathematical model for the extrinsic activation of coagulation. Haemostasis 24, 325-337 (1994). (Pubitemid 24330682)
18. Khanin, M.A., Rakov, D.V. & Kogan, A.E. Mathematical model for the blood coagulation prothrombin time test. Thromb. Res. 89, 227-232 (1998).
19. Kogan, A.E., Kardakov, D.V. & Khanin, M.A. Analysis of the activated partial thromboplastin time test using mathematical modeling. Thromb. Res. 101, 299-310 (2001).
20. Lwaleed, B.A. & Bass, P.S. Tissue factor pathway inhibitor: structure, biology and involvement in disease. J. Pathol. 208, 327-339 (2006).
21. Choonara, I.A. et al. The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin. Br. J. Clin. Pharmacol. 25, 1-7 (1988).
22. Holford, N.H. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. Clin. Pharmacokinet. 11, 483-504 (1986).
23. Colman, R.W., Scott, C.F., Pixley, R.A. & de la Cadena, R.A. Effect of heparin on the inhibition of the contact system enzymes. Ann. NY Acad. Sci. 556, 95-103 (1989).
24. Green, B. & Duffull, S.B. Development of a dosing strategy for enoxaparin in obese patients. Br. J. Clin. Pharmacol. 56, 96-103 (2003). (Pubitemid 36886494)
25. Holmer, E., Kurachi, K. & Söderström, G. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. Biochem. J. 193, 395-400 (1981). (Pubitemid 11141360)
26. Mann, K.G. Biochemistry and physiology of blood coagulation. Thromb. Haemost. 82, 165-174 (1999).
27. Booth, S.L., Tucker, K.L., McKeown, N.M., Davidson, K.W., Dallal, G.E. & Sadowski, J.A. Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans. J. Nutr. 127, 587-592 (1997).
28. Booth, S.L., Davidson, K.W., Lichtenstein, A.H. & Sadowski, J.A. Plasma concentrations of dihydro-vitamin K1 following dietary intake of a hydrogenated vitamin K1-rich vegetable oil. Lipids 31, 709-713 (1996).
29. Bach, A.U., Anderson, S.A., Foley, A.L., Williams, E.C. & Suttie, J.W. Assessment of vitamin K status in human subjects administered "minidose" warfarin. Am. J. Clin. Nutr. 64, 894-902 (1996).
30. Dickinson, G.L., Lennard, M.S., Tucker, G.T. & Rostami-Hodjegan, A. The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example. Br. J. Clin. Pharmacol. 64, 14-26 (2007). (Pubitemid 46934416)
31. Lovenox [prescribing information]. Bridgewater, NJ: sanofi-aventis, 1993. 〈http://products.sanofi-aventis.us/lovenox/lovenox.html〉
32. Kim, K.Y., Yang, C.H., Cho, M.J. & Lee, M. Comprehensive clinical and statistical analysis of hemophilia in Korea. J. Korean Med. Sci. 3, 107-115 (1988). (Pubitemid 19050884)
33. Lalloo, D.G. et al. Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni). Blood Coagul. Fibrinolysis 6, 65-72 (1995).
34. Mann, K.G., Brummel-Ziedins, K., Orfeo, T. & Butenas, S. Models of blood coagulation. Blood Cells Mol. Dis. 36, 108-117 (2006).
35. Hamberg, A.K. et al. A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapy. Clin. Pharmacol. Ther. 81, 529-538 (2007).
36. Pitsiu, M., Parker, E.M., Aarons, L. & Rowland, M. A Bayesian method based on clotting factor activity for the prediction of maintenance warfarin dosage regimens. Ther. Drug Monit. 25, 36-40 (2003). (Pubitemid 36139823)
37. Sharma, A. & Jusko, W.J. Characteristics of indirect pharmacodynamic models and applications to clinical drug responses. Br. J. Clin. Pharmacol. 45, 229-239 (1998). (Pubitemid 28081918)
38. Bechtold, H., Trenk, D., Meinertz, T., Rowland, M. & Jähnchen, E. Cyclic interconversion of vitamin K1 and vitamin K1 2,3-epoxide in man. Br. J. Clin. Pharmacol. 16, 683-689 (1983).
39. Stoeckel, K., Joubert, P.H. & Grüter, J. Elimination half-life of vitamin K1 in neonates is longer than is generally assumed: implications for the prophylaxis of haemorrhaghic disease of the newborn. Eur. J. Clin. Pharmacol. 49, 421-423 (1996). (Pubitemid 126423997)